We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Volume 31 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Increased risk of stroke in older women should be taken into account in prescribing decisions.
Projects granted during 2016 that have a primary purpose of translational research - human urogenital/reproductive disorders.
New data have confirmed that the risk of breast cancer is increased during use of all types of HRT, except vaginal estrogens, and have also shown that an excess risk of breast cancer persists for longer after stopping HRT than previously thought.…
Population-based statistics on diagnostic intervals for cancer patients for 24 cancer types diagnosed in 2014 and 2015 in England.
1-year and 5-year net-survival estimates for men, women and persons in England, by NHS Region, Cancer Alliance, and Sustainability and Transformation Partnerships.…
Conditional crude probabilities of death, split by cancer and non-cancer causes, for adult cancer patients diagnosed between 2014 to 2018.
Cancer diagnoses and age-standardised incidence rates for all types of cancer by age and sex.
One-year and 3-year case-mix adjusted percentage of cancers diagnosed at stages 1 and 2, as compared to stages 1 to 4, by Clinical Commissioning Group for 21 cancer groups.…
Before prescribing hormone-replacement therapy, healthcare professionals should consider carefully the potential benefits and risks for every woman
This leaflet is sent to all women invited for NHS cervical screening.
Cancer survival statistics for adults and children by stage at diagnosis and by different geographical variations.…
Population-based statistics on cancers treated with chemotherapy, radiotherapy and surgical tumour resection which were diagnosed between 2013 and 2016 in England.
Guidance to support people who find it hard to attend cervical screening due to a mental health condition, previous traumatic experience or sexual and/or domestic abuse.
Public consultation on a set of proposals to make Gina 10 microgram vaginal tablets (Estradiol) available from pharmacies.
Employment Tribunal decision.
Details the government’s 10-year ambitions and the actions we are taking now to improve the health and wellbeing of women and girls in England.
Quality and Methodology Information for the NCRAS statistical publications, detailing the strengths and limitations of the data, methods used, and data uses.
Guidelines for commissioners, screening providers and programme managers for NHS cervical screening.
Guidance on the training of new cervical sample takers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).